D9.1 – Report on models identified to be developed (PDF)
D9.2 – Report on predictions from first model (PDF)
D9.3 – Establishment of PK models for prediction of DDI and genetic polymorphisms on drug exposure for candidate genes included in the U-PGx trial
D9.4 – Report on design of future study employing one promising model
D9.5 – Report on predictions from further models
D9.6 – Detection, assessment and evaluation of clinically relevant DDI in the U-PGx trial
D9.7 – Report on comparison of model predictions and observed data from WP4
D9.8 – Critical re-evaluation and first implementation of revised DPWG guidelines by consideration of relevant DDI